BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05428007-completion@plaintrial.com
DTSTAMP:20261027T081739Z
DTSTART;VALUE=DATE:202802
SUMMARY:Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipil
 imumab\, Nivolumab and Relatlimab in Patients With Unresectable Stage III 
 or Stage IV Melanoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05428007
URL:https://plaintrial.com/trial/NCT05428007
END:VEVENT
END:VCALENDAR